SCA
AGN

Stonebridge Capital Advisors’s Allergan plc AGN Stock Holding History

Stonebridge Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50
Closed -$10K – 893
2019
Q4 		$10K Sell
50
-30
-38% -$5.41K ﹤0.01% 567
2019
Q3 		$13K Hold
80
– – ﹤0.01% 527
2019
Q2 		$13K Sell
80
-11,794
-99% -$1.63M ﹤0.01% 537
2019
Q1 		$1.74M Buy
11,874
+775
+7% +$112K 0.32% 85
2018
Q4 		$1.48M Sell
11,099
-1,165
-9% -$191K 0.35% 79
2018
Q3 		$2.34M Sell
12,264
-185
-1% -$34K 0.47% 67
2018
Q2 		$2.08M Buy
12,449
+1,350
+12% +$217K 0.45% 68
2018
Q1 		$1.87M Buy
11,099
+7
+0.1% +$1.17K 0.43% 72
2017
Q4 		$1.81M Buy
11,092
+70
+0.6% +$12.6K 0.42% 75
2017
Q3 		$2.26M Sell
11,022
-391
-3% -$90.9K 0.56% 62
2017
Q2 		$2.77M Buy
11,413
+155
+1% +$36.4K 0.73% 54
2017
Q1 		$2.69M Buy
11,258
+398
+4% +$92.7K 0.73% 55
2016
Q4 		$2.28M Buy
10,860
+373
+4% +$77.3K 0.68% 55
2016
Q3 		$2.42M Buy
10,487
+1,480
+16% +$362K 0.76% 50
2016
Q2 		$2.08M Buy
+9,007
New +$2.08M 0.71% 53

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stonebridge Capital Advisors's AGN Position: Q1 2020 in Review

Stonebridge Capital Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 50 shares — an estimated $10K sold.

Stonebridge Capital Advisors first reported a position in AGN in Q2 2016 and held it in 15 quarters. The position peaked at $2.77M in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Stonebridge Capital Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 50 Allergan plc shares in Q1 2020, an estimated $10K.
  • Stonebridge Capital Advisors first reported a position in Allergan plc in Q2 2016 and held it in 15 quarters.
  • Stonebridge Capital Advisors's Allergan plc position peaked at $2.77M in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2020, filed 15 May 2020.